An evidence-based comparison of operational criteria for the presence of sarcopenia
- PMID: 24737561
- PMCID: PMC3991139
- DOI: 10.1093/gerona/glu013
An evidence-based comparison of operational criteria for the presence of sarcopenia
Abstract
Background: Several consensus groups have previously published operational criteria for sarcopenia, incorporating lean mass with strength and/or physical performance. The purpose of this manuscript is to describe the prevalence, agreement, and discrepancies between the Foundation for the National Institutes of Health (FNIH) criteria with other operational definitions for sarcopenia.
Methods: The FNIH Sarcopenia Project used data from nine studies including: Age, Gene and Environment Susceptibility-Reykjavik Study; Boston Puerto Rican Health Study; a series of six clinical trials from the University of Connecticut; Framingham Heart Study; Health, Aging, and Body Composition Study; Invecchiare in Chianti; Osteoporotic Fractures in Men Study; Rancho Bernardo Study; and Study of Osteoporotic Fractures. Participants included in these analyses were aged 65 and older and had measures of body mass index, appendicular lean mass, grip strength, and gait speed.
Results: The prevalence of sarcopenia and agreement proportions was higher in women than men. The lowest prevalence was observed with the FNIH criteria (1.3% men and 2.3% women) compared with the International Working Group and the European Working Group for Sarcopenia in Older Persons (5.1% and 5.3% in men and 11.8% and 13.3% in women, respectively). The positive percent agreements between the FNIH criteria and other criteria were low, ranging from 7% to 32% in men and 5% to 19% in women. However, the negative percent agreement were high (all >95%).
Conclusions: The FNIH criteria result in a more conservative operational definition of sarcopenia, and the prevalence was lower compared with other proposed criteria. Agreement for diagnosing sarcopenia was low, but agreement for ruling out sarcopenia was very high. Consensus on the operational criteria for the diagnosis of sarcopenia is much needed to characterize populations for study and to identify adults for treatment.
Keywords: Lean mass.; Muscle; Sarcopenia.
Figures
Similar articles
-
The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58. doi: 10.1093/gerona/glu010. J Gerontol A Biol Sci Med Sci. 2014. PMID: 24737557 Free PMC article.
-
Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.J Gerontol A Biol Sci Med Sci. 2014 May;69(5):576-83. doi: 10.1093/gerona/glu012. J Gerontol A Biol Sci Med Sci. 2014. PMID: 24737560 Free PMC article.
-
Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness.J Gerontol A Biol Sci Med Sci. 2014 May;69(5):567-75. doi: 10.1093/gerona/glu023. J Gerontol A Biol Sci Med Sci. 2014. PMID: 24737559 Free PMC article.
-
Considerations concerning the definition of sarcopenia.Osteoporos Int. 2016 Nov;27(11):3139-3144. doi: 10.1007/s00198-016-3674-8. Epub 2016 Jun 21. Osteoporos Int. 2016. PMID: 27329218 Free PMC article. Review.
-
Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults.Geriatr Gerontol Int. 2016 Mar;16 Suppl 1:110-22. doi: 10.1111/ggi.12723. Geriatr Gerontol Int. 2016. PMID: 27018289 Review.
Cited by
-
Sarcopenic Obesity as a Risk Factor for Cardiovascular Disease: An Underrecognized Clinical Entity.Heart Int. 2023 Dec 1;17(2):6-11. doi: 10.17925/HI.2023.17.2.6. eCollection 2023. Heart Int. 2023. PMID: 38419720 Free PMC article. Review.
-
Immunogenetic Aspects of Sarcopenic Obesity.Genes (Basel). 2024 Feb 5;15(2):206. doi: 10.3390/genes15020206. Genes (Basel). 2024. PMID: 38397196 Free PMC article. Review.
-
Korean Nationwide Exploration of Sarcopenia Prevalence and Risk Factors in Late Middle-Aged Women.Healthcare (Basel). 2024 Jan 31;12(3):362. doi: 10.3390/healthcare12030362. Healthcare (Basel). 2024. PMID: 38338247 Free PMC article.
-
Higher systemic immune-inflammation index is associated with sarcopenia in individuals aged 18-59 years: a population-based study.Sci Rep. 2023 Dec 13;13(1):22156. doi: 10.1038/s41598-023-49658-1. Sci Rep. 2023. PMID: 38092854 Free PMC article.
-
The diagnostic cut-off points for components of sarcopenia in Finnish Caucasian women: A retrospective cross-sectional study.J Frailty Sarcopenia Falls. 2023 Dec 1;8(4):211-220. doi: 10.22540/JFSF-08-211. eCollection 2023 Dec. J Frailty Sarcopenia Falls. 2023. PMID: 38046438 Free PMC article.
References
-
- Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–763 - PubMed
-
- Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010;29(2): 154–159. 10.1016/j.clnu.2009.12.004 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
